Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00056420 · ClinicalTrials.gov registry record

Brain Dynamics Involved in Generating Tics and Controlling Voluntary Movement

A clinical trial of Tourette Syndrome and Tic Disorders, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Completed
Registry status
54
Enrollment target
1
Study location

NCT00056420: Completed study of Tourette Syndrome and Tic Disorders, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

NCT00056420 is a study of Tourette Syndrome and Tic Disorders that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 54 participants, below the 85-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00056420, a study of Tourette Syndrome and Tic Disorders, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

COMPLETED
Registry status
54 participants
Enrollment target
1
Study location

Study Summary

This study will use electroencephalography (EEG) and electromyography (EMG) to examine how the brain generates tics and controls voluntary movement in patients with Tourette's syndrome and chronic motor tic disorder. EEG records the electrical activity of the brain. For this test, a cap with built-in electrodes is placed on the subject's head, and the electrodes are connected to a monitor that records the brain activity. EMG records muscle activity using electrodes placed on the skin over muscles on the fingers or above the outer corner of the eyes. Healthy normal volunteers and patients with Tourette's syndrome and chronic motor tic disorder between 21 and 65 years of age may be eligible for this 2- to 3-hour study. Each candidate will be screened with a medical history, physical and neurological examinations, and a questionnaire that screens for psychiatric disorders. During EEG and EMG recordings, participants undergo the following tasks while seated comfortably in a sound-shielded room: Patients * Finger task: Patients raise their index finger once every 10 seconds for about 25 minutes. * Tic evaluation and mimicking: Patients allow their tics to occur as they do naturally. After each tic, they report whether the tic was voluntary and whether it was preceded by a sensation of urge. They then mimic tics that they normally have, at a rate of about once every 10 seconds. * Tic suppression task: Patients suppress tics they normally have for several minutes. They then allow the tics to occur naturally, without attempting to suppress them. Normal Volunteers * Finger task: Volunteers raise their index finger once every 10 seconds for about 25 minutes. * Open eye task: Volunteers keep their eyes open for a minute or so, and then resume blinking as often as feels comfortable. The process is repeated several times.

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2003-03-10
Est. Completion 2009-01-22

What the finished NCT00056420 record still lists

NCT00056420 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 85-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (36% lower).

The record links to 2 conditions, with Tourette Syndrome appearing as the primary indexed condition, and to 0 interventions.

NCT00056420 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00056420 about?

NCT00056420 is a clinical study titled "Brain Dynamics Involved in Generating Tics and Controlling Voluntary Movement". This study will use electroencephalography (EEG) and electromyography (EMG) to examine how the brain generates tics and controls voluntary movement in patients with Tourette's syndrome and chronic motor tic disorder. EEG records the electrical activity of the brain. For this test, a cap with built-i...

What is the current status of trial NCT00056420?

This trial is currently completed. The enrollment target is 54 participants. The study started on 2003-03-10. Estimated completion is 2009-01-22.

What conditions does trial NCT00056420 study?

This clinical trial studies the following conditions: Tourette Syndrome, Tic Disorders.

Who is sponsoring clinical trial NCT00056420?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00056420 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tourette Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00056420's enrollment target sits among peer trials

54 16th of 33 higher than 17 of 33 other Tourette Syndrome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Tourette Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01269853 · 54 participants · Phase 1

    Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA

  • NCT02390752 · 54 participants · Phase 1

    Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

  • NCT02991248 · 54 participants · NA

    Improve Dynamic Lateral Balance of Humans With SCI

  • NCT02993900 · 54 participants · NA

    Image-Guided Gynecologic Brachytherapy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00056420, the US trial registry maintained by the National Library of Medicine. NCT00056420 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.